Top

Published in:

01-09-2009 | Topic Review

The relationships between depression and brain tumors

Authors: N. Scott Litofsky, Andrew G. Resnick

Published in: Journal of Neuro-Oncology | Issue 2/2009

Abstract

Depression is a common complication/co-morbidity in patients with brain tumors. Better understanding of the relationships between brain tumors and depression should lead to improvement in patient care. This paper reviews these relationships in order to direct further study to improve patient care, and hopefully, outcome. Both anatomic and physiological perturbations in the brain are likely involved in the associations between depression and brain tumors. Tumor treatments are also associated with depression. Depression has a significant negative impact on outcome in brain tumor patients. The role of treatment of depression in brain tumor patients has been scantly studied. Further investigation directed to these areas of knowledge deficit should benefit depressed patients with brain tumors.

Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER, Glioma Outcomes Project Investigators (2004) Depression in patients with high grade glioma: results of the glioma outcomes project. Neurosurgery 54:358–367. doi:10.1227/01.NEU.0000103450.94724.A2 PubMedCrossRef

Kaplan CP, Miner ME (2000) Relationships: importance for patients with cerebral tumours. Brain Inj 14:251–259. doi:10.1080/026990500120727 PubMedCrossRef

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, text revision, 4th edn. American Psychiatric Association, Washington, DCCrossRef

Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2005) Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 103:841–847PubMedCrossRef

Moise D, Madhusoodanan S (2006) Psychiatric symptoms associated with brain tumors: a clinical enigma. CNS Spectr 11:28–31PubMed

Madhusoodanan S, Danan D, Brenner R, Bogunovic O (2004) Brain tumor and psychiatric manifestations: a case report and brief review. Ann Clin Psychiatry 16:111–113. doi:10.1080/10401230490453770 PubMed

Filley CM, Kleinschmidt-DeMasters BK (1951) Neurobehavioral presentations of brain neoplasms. West J Med 163:19–25

Winkour G (1990) The concept of a secondary depression and its relationship to comorbidity. Psychiatr Clin North Am 123:567–583

Stenager EA, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296–1303PubMed

10.

Furgal-Borzych A, Lis GJ, Litwin JA, Rzepecka-Wozniak E, Trela F, Cichocki T (2007) Increased incidence of pituitary microadenomas in suicide victims. Neuropsychobiology 55:163–166. doi:10.1159/000106475 PubMedCrossRef

11.

Valentine A, Passik S, Massie MJ (2002) Psychiatric and psychosocial issues. In: Levin V (ed) Cancer in the nervous system, 2nd edn. University Press, Oxford, pp 572–589

12.

Anderson SI, Taylor R (1999) Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 13:480–485PubMed

13.

Takei N, Sugihara G (2006) Diagnostic ambiguity of subthreshold depression: minor depression versus adjustment disorder with depressed mood. Acta Psychiatr Scand 114:144. doi:10.1111/j.1600-0447.2006.00802.x PubMedCrossRef

14.

Cuijpers P, Smith F, van Stralen A (2007) Psychological treatments of subthreshold depression: a meta-analysis review. Acta Psychiatr Scand 115:434–441. doi:10.1111/j.1600-0447.2007.00998.x PubMedCrossRef

15.

Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41–49. doi:10.1023/A:1015728825642 PubMedCrossRef

16.

Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM (2006) Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 154:483–489. doi:10.1530/eje.1.02114 PubMedCrossRef

17.

Stoll T, Kauer Y, Buchi S, Klaghofer R, Sensky T, Villiger PM (2001) Prediction of depression in systemic lupus erythematosus patients using SF-36 mental health scores. Rheumatology 40:695–698. doi:10.1093/rheumatology/40.6.695 PubMedCrossRef

18.

Whooley MA, Avins AL, Miranda J, Browner WS (1997) Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 12:439–445. doi:10.1046/j.1525-1497.1997.00076.x PubMedCrossRef

19.

Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562–568. doi:10.1136/jnnp.2004.036186 PubMedCrossRef

20.

Fox SW, Lyon D, Farace E (2007) Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 39:61–67. doi:10.1111/j.1547-5069.2007.00144.x PubMedCrossRef

21.

Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364–3369. doi:10.1210/jc.2006-0003 PubMedCrossRef

22.

Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 61:458–465. doi:10.1111/j.1365-2265.2004.02118.x CrossRef

23.

Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13:46–51. doi:10.1080/02688699944177 PubMedCrossRef

24.

Reavley A, Fisher AD, Owen D, Creed FH, Davis JR (1997) Psychological distress in patients with hyperprolactinemia. Clin Endocrinol (Oxf) 47:343–348. doi:10.1046/j.1365-2265.1997.2701073.x CrossRef

25.

Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21:194–199. doi:10.1016/j.eurpsy.2005.05.008 PubMedCrossRef

26.

Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56:1234–1241. Discussion 1241–1242. doi:10.1227/01.NEU.0000159648.44507.7F PubMedCrossRef

27.

Kaplan CP, Miner ME (1997) Anxiety and depression in elderly patients receiving treatment for cerebral tumours. Brain Inj 11:129–135. doi:10.1080/026990597123728 PubMedCrossRef

28.

Armstrong TS, Mendoza T, Gring I, Coco C, Cohen MZ, Eriksen L, Hsu M-A, Gilbert MR (2006) Validation of the M.D. Anderson symptom inventory brain tumor module (MDASI-BT). J Neurooncol 80:27–35CrossRef

29.

Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Gupta L, Tang-Wai DF, Arusell RM, Clark MM, Buckner JC (2006) Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 76:283–291. doi:10.1007/s11060-005-7020-9 PubMedCrossRef

30.

Mackworth N, Fobair P, Prados MD (1992) Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 14:243–253. doi:10.1007/BF00172600 PubMedCrossRef

31.

Wellish DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J (2002) Predicting major depression in brain tumor patients. Psychooncology 11:230–238. doi:10.1002/pon.562 CrossRef

32.

Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, Guill AB, Herndon JE, Raynor RH (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10:171–181. doi:10.1215/15228517-2007-057 PubMedCrossRef

33.

Price TR, Goetz KL, Lowell MR (1997) Neuropsychiatric aspects of brain tumors. In: Yudofsky SC, Hales RE (eds) The American psychiatric press textbook of neuropsychiatry, 3rd edn. American Psychiatric Press, Washington, DC, pp 635–662

34.

Benson DF, Geschqind N (1974) Psychiatric conditions associated with focal lesions of the central nervous system. In: Arieti S, Freedman DX, Hamburg (eds) American handbook of psychiatry, 2nd edn. Basic books, New York

35.

Cole G (1978) Intracranial space-occupying masses in mental hospital patients: necropsy study. J Neurol Neurosurg Psychiatry 41:730–736. doi:10.1136/jnnp.41.8.730 PubMedCrossRef

36.

Fischer CE (2004) Experience of electroconvulsive therapy in a case of glioblastoma multiforme. Psychiatry Clin Neurosci 58:671. doi:10.1111/j.1440-1819.2004.01320.x PubMedCrossRef

37.

Kohler CG, Burock M (2001) ECT for psychotic depression associated with a brain tumor. Am J Psychiatry 158:2089. doi:10.1176/appi.ajp.158.12.2089 PubMedCrossRef

38.

Spence SA, Taylor DG, Hirsch SR (1995) Depressive disorder due to craniopharyngioma. J R Soc Med 88:637–638PubMed

39.

Tanaghow A, Lewis J, Jones GH (1989) Anterior tumour of the corpus callosumwith atypical depression. Br J Psychiatry 155:854–856. doi:10.1192/bjp.155.6.854 PubMedCrossRef

40.

Galasko D, Kwo-On-Yuen PF, Thal L (1988) Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am 11:151–166PubMed

41.

Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, Boeve BF, Arusell RM, Clark MM, Buckner JC (2005) A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495–504. Discussion 495–504. doi:10.1227/01.NEU.0000170562.25335.C7 PubMedCrossRef

42.

Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A, Weingart JD, Brem H, Quinones-Hinojosa A (2008) Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol (September):10. (Epub ahead of print)

43.

Huang ME, Wartella J, Kreutzer J, Broaddus W, Lyckholm L (2001) Functional outcomes and quality of life in patients with brain tumours: a review of the literature. Brain Inj 15:843–856. doi:10.1080/02699050010013653 PubMedCrossRef

44.

Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV (2004) Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh 36:197–206. doi:10.1111/j.1547-5069.2004.04038.x PubMedCrossRef

45.

Uribe VM (1986) Psychiatric symptoms and brain tumor. Am Fam Physician 34:95–98PubMed

46.

Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999. doi:10.1016/S0360-3016(02)04205-0 PubMed

47.

Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. QJM 89:543–551PubMedCrossRef

48.

Weitzner MA, Kanfer S, Booth-Jones M (2005) Apathy and pituitary disease: it has nothing to do with depression. J Neuropsychiatry Clin Neurosci 17:159–166. doi:10.1176/appi.neuropsych.17.2.159 PubMed

49.

Steinbach JP, Blaicher HP, Herrlinger U, Wick W, Nagele T, Meyerman R, Tatagiba M, Bamberg M, Dichgans J, Karnath HO, Weller M (2006) Surviving glioblastoma for more than 5 years: the patient’s perspective. Neurology 66:239–242. doi:10.1212/01.wnl.0000194221.89948.a0 PubMedCrossRef

50.

Herrmann M, Curio N, Petz T, Synowitz H, Wagner S, Bartels C, Wallesch CW (2000) Coping with illness after brain diseases—a comparison between patients with malignant brain tumors, stroke, Parkinson’s disease and traumatic brain injury. Disabil Rehabil 22:539–546. doi:10.1080/096382800416788 PubMedCrossRef

51.

Ross L, Johansen C, Dalton SO, Mellemkjaer L, Thomassen LH, Mortensen PB, Olsen JH (2003) Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. N Engl J Med 349:650–657. doi:10.1056/NEJMoa022672 PubMedCrossRef

52.

Chow E, Davis L, Holden L, Tsao M, Danjoux C (2005) Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J Pain Symptom Manag 30:18–23. doi:10.1016/j.jpainsymman.2005.02.009 PubMedCrossRef

53.

Taphoorn MJ, Schiphorst AK, Snoek FJ, Lindeboom J, Wolbers JG, Karim AB, Huijgens PC, Heimans JJ (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36:48–54. doi:10.1002/ana.410360111 PubMedCrossRef

54.

Jason GW, Pajurkova EM, Taenzer PA, Bultz BD (1997) Acute effects on neuropsychological function and quality of life by high-dose multiple daily fractionated radiotherapy for malignant astrocytomas: assessing the tolerability of a new radiotherapy regimen. Psychooncology 6:151–157. doi:10.1002/(SICI)1099-1611(199706)6:2<151::AID-PON244>3.0.CO;2-G PubMedCrossRef

55.

Pies R (1995) Differential diagnosis of steroid-induced affective disorders. Gen Hosp Psychiatry 17:353–361. doi:10.1016/0163-8343(95)00063-W PubMedCrossRef

56.

Baldessari RJ (2006) Chapter 17. Drug therapy of depression and anxiety disorders. In Brunton LL (editor-in-chief). Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. The McGraw Hill Companies, Inc, USA. (on-line edition)

57.

Hall G, Fitzgerald DJ (2008) Chapter 47. Psychiatric emergencies. In Stone CK, Humpries RL (eds) Current diagnosis and treatment: emergency medicine, 6th edn. The McGraw Hill Companies, Inc.(on-line edition)

58.

Rabheru K (2001) The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 46:710–719PubMed

59.

Patkar AA, Hill KP, Weinstein SP, Schwartz SL (2000) ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. J ECT 16:189–197. doi:10.1097/00124509-200006000-00011 PubMedCrossRef

Title: The relationships between depression and brain tumors
Authors: N. Scott Litofsky
Andrew G. Resnick
Publication date: 01-09-2009
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2009
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-009-9825-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The relationships between depression and brain tumors

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Primary leptomeningeal oligodendrogliomatosis

Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma

Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients

The role of Gamma Knife surgery in the treatment of skull base chordomas

Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature

Mutations of IDH1 and IDH2 are not detected in brain metastases of colorectal cancer